Skip to main content

Featured

Tehran Rocked by Renewed Israeli Strikes as Iran’s Leadership Council Assumes Control

  A woman reacts as she holds a placard with an image of Iranian late Supreme Leader Ayatollah Ali Khamenei, at a rally in solidarity with Iran after U.S. and Israeli strikes killed Ali Khamenei, in Beirut, Lebanon. Israel has launched another wave of airstrikes on Tehran, intensifying a rapidly escalating regional crisis just one day after the assassination of Iran’s Supreme Leader, Ali Khamenei. According to multiple reports, Israeli officials said the renewed strikes were intended to maintain air dominance as Iran faces its most significant leadership vacuum in decades.  The power void left by Khamenei’s killing has prompted Iran to activate a leadership council to stabilize governance. Inside the country, reactions have been sharply divided—some mourning the long‑time leader, others openly celebrating his death, revealing deep internal fractures.  The military confrontation has widened beyond Iran’s borders. Iran has retaliated with missile barrages targeting Israe...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment